BRIEF published on 07/31/2024 at 06:05, 1 year 10 months ago Bausch Health publie ses résultats financiers du deuxième trimestre 2024 Résultats Financiers EBITDA Ajusté Hausse Des Revenus Bausch Santé Performances Sectorielles
PRESS RELEASE published on 07/31/2024 at 06:00, 1 year 10 months ago Bausch Health Announces Second Quarter 2024 Results Bausch Health announced second quarter 2024 financial results with $2.40 billion revenues, 11% increase. Raised full-year Revenue and Adjusted EBITDA guidance Revenues Financial Results EBITDA Bausch Health Guidance
BRIEF published on 07/24/2024 at 18:55, 1 year 11 months ago Bausch Health Responds to Market Rumors Bausch Health Bankruptcy Financial Stability Market Rumors Reorg Update
BRIEF published on 07/24/2024 at 18:55, 1 year 11 months ago Bausch Health répond aux rumeurs du marché Bausch Santé Stabilité Financière La Faillite Rumeurs De Marché Mise À Jour De La Réorganisation
PRESS RELEASE published on 07/24/2024 at 18:50, 1 year 11 months ago Bausch Health Responds to Market Rumors Bausch Health refutes rumors of bankruptcy discussions. The global pharmaceutical company emphasizes its commitment to delivering better healthcare outcomes Pharmaceutical Company Healthcare Outcomes Bausch Health Bankruptcy Rumors
BRIEF published on 07/19/2024 at 13:05, 1 year 11 months ago Bausch Health Welcomes Two New Members to the Executive Leadership Team Pharmaceutical Industry Bausch Health Financial Leadership Executive Leadership Corporate Appointments
BRIEF published on 07/19/2024 at 13:05, 1 year 11 months ago Bausch Health accueille deux nouveaux membres au sein de son équipe de direction Bausch Santé Leadership Financier Leadership Executif Industrie Pharmaceutique Rendez-vous Corporatifs
PRESS RELEASE published on 07/19/2024 at 13:00, 1 year 11 months ago Bausch Health Welcomes Two New Members to the Executive Leadership Team Bausch Health Companies Inc. appoints new Chief Financial Officer and Executive Vice President, reinforcing leadership team to drive transformation. Detailed experience of new members provided in the press release Chief Financial Officer Bausch Health Companies Inc. Appointment Executive Vice President Executive Leadership Team
BRIEF published on 07/11/2024 at 13:05, 1 year 11 months ago Bausch Health to Announce Second Quarter 2024 Results on August 1, 2024 Financial Results Conference Call Investor Relations Bausch Health 2024 Second Quarter
BRIEF published on 07/11/2024 at 13:05, 1 year 11 months ago Bausch Health annoncera ses résultats du deuxième trimestre 2024 le 1er août 2024 Résultats Financiers Conférence Téléphonique Relations Avec Les Investisseurs Bausch Santé Deuxième Trimestre 2024
Published on 06/27/2026 at 16:50, 6 hours 33 minutes ago Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 21 hours 43 minutes ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 23 hours 23 minutes ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 1 day ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 1 day ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/27/2026 at 00:05, 23 hours 18 minutes ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 23 hours 19 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 23 hours 47 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 23 hours 47 minutes ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 23 hours 56 minutes ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
